Brief: Simcere Pharmaceutical To Repurchase Shares In Open Market Up To RMB1,000 Million
20/08/2026 16:21
BRIEF-Simcere Pharmaceutical To Repurchase Shares In Open Market Up To RMB1,000 Million Aug 20 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK:
TO REPURCHASE SHARES IN OPEN MARKET UP TO RMB1,000 MILLION
SHARE REPURCHASE PERIOD FROM AUG 21, 2026 UNTIL NEXT AGM OR EARLIER IF AUTHORITY REVOKED
Further company coverage: 2096.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660